Califf Lowering FDA Drawbridge To Work With External Expertise
This article was originally published in The Rose Sheet
In an exclusive interview, new commissioner Robert Califf says FDA will tap knowledge beyond its walls, without compromising agency independence.
You may also be interested in...
Former commissioner says agency has to think about getting biggest bang for the buck when considering a reorganization to disease-focused teams.
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.
FDA’s drug center continues to operate with a staffing shortage at a time of tremendous pressure to implement new authorities, with Director Janet Woodcock scrambling to find senior managers to lead top initiatives. Direct hiring authority has helped but doesn’t fully address FDA’s recruiting challenges: too much red tape and too little money.